| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $73.7M | — | +14.2% |
| Cost of Revenue | $13.7M | — | -31.2% |
| Gross Profit | $60.0M | — | +34.3% |
| R&D Expense | $14.6M | — | +52.1% |
| SG&A Expense | $11.5M | — | -43.9% |
| Operating Income | $9.6M | — | +224.0% |
| Pre-tax Income | $11.6M | — | +145.7% |
| Income Tax | $2.9M | — | +166.3% |
| Net Income | $8.8M | — | +141.5% |
| EPS (Basic) | $0.12 | — | +108.5% |
| EPS (Diluted) | $0.11 | — | +107.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $213.9M | +1.8% | — |
| Accounts Receivable | $56.3M | -8.9% | — |
| Current Assets | $283.4M | -1.1% | — |
| Total Assets | $375.1M | -0.8% | — |
| Current Liabilities | $52.1M | -23.9% | — |
| Total Liabilities | $56.5M | -22.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $7.1M | — | +261.1% |
| Investing Cash Flow | -$3.4M | — | -14.1% |
| Financing Cash Flow | $66K | — | -91.1% |
| Stockholders' Equity | $318.6M | +4.2% | +379.7% |